Safety And Efficacy Of Impella RP Support For Acute Right Ventricular Failure Complicated By Cardiogenic Shock: Post Market Approval Sub-Analysis Of The CVAD Registry
Shah Y, Shah T, Schwartz A, Poddar K, O'Neill W, Anderson M, Wohns D, Meraj P, Palacios I, Kapur N, Almedhychy A, Lansky A. Safety And Efficacy Of Impella RP Support For Acute Right Ventricular Failure Complicated By Cardiogenic Shock: Post Market Approval Sub-Analysis Of The CVAD Registry. Journal Of Cardiac Failure 2024, 30: 269. DOI: 10.1016/j.cardfail.2023.10.361.Peer-Reviewed Original ResearchPercutaneous right ventricular assist deviceAcute right ventricular failureRight ventricular failureIschemic brain injuryCardiogenic shockAcute myocardial infarctionImpella RPSalvage groupCVAD RegistryRefractory shockBrain injuryPost-cardiotomy cardiogenic shockRight ventricular assist deviceVentricular assist device placementInotropes/vasopressorsNon-approved indicationsHospital adverse eventsHospital cardiac arrestOngoing cardiopulmonary resuscitationVentricular assist deviceDuration of shockHospital mortalityMajor bleedingCardiac indexVentricular failure